Goldman Sachs Removes Clorox (CLX) from its Conviction Buy List
More News related to CLX
- Clorox Announces Pricing of $300 Million Senior Notes
- The Clorox Company Joins the Business Coalition for Workplace Fairness
- The Makers of Clorox(R) Clean-Up(R) to Award $50,000 to Kids' Programs Through New Power A Bright Future Grant Program
- Clorox (CLX) Benefits In Q1 From H1N1 Fears (Update)
- Clorox (CLX) Tops Q1 EPS Views; Guides In-Line
Goldman Sachs removes Clorox Corporation (NYSE: CLX) from its Conviction Buy List. The firm has a Buy rating and $63 price target on CLX.
The Clorox Company manufactures and markets a range of consumer products.
Related Categories
Analyst CommentsStocks Mentioned
+0.46Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
